Actovegin®: a biological drug for more than 5 decades
- PMID: 21404144
- DOI: 10.1007/s10354-011-0865-y
Actovegin®: a biological drug for more than 5 decades
Erratum in
- Wien Med Wochenschr. 2011 May;161(9-10):280
Abstract
Actovegin(®) is a biological drug manufactured from a natural source: it is a calf blood hemodialysate. Its therapeutic benefits stem from a variety of pharmacodynamic actions that can be summarized to a common goal, i.e. the enhancement of cellular metabolism; this results from an insulin-like activity mediated by Inositol-phospho-oligosaccharides. Actovegin(®) results in beneficial effects in several pathophysiological clinical settings including malfunction of the blood circulation and trophic disturbances in the brain, impairment of peripheral blood circulation and associated diseases, dermal transplants and acute and chronic wounds. Here, we give an overview of the pharmacodynamic actions of calf-blood hemidialysate and its beneficial effects in a variety of clinical settings.
Similar articles
-
Pleiotropic neuroprotective and metabolic effects of Actovegin's mode of action.J Neurol Sci. 2012 Nov 15;322(1-2):222-7. doi: 10.1016/j.jns.2012.07.069. Epub 2012 Aug 19. J Neurol Sci. 2012. PMID: 22910148 Review.
-
Highly purified calf hemodialysate (Actovegin®) may improve endothelial function by activation of proteasomes: A hypothesis explaining the possible mechanisms of action.Med Hypotheses. 2016 Oct;95:77-81. doi: 10.1016/j.mehy.2016.09.008. Epub 2016 Sep 16. Med Hypotheses. 2016. PMID: 27692173
-
Current Synthesis and Systematic Review of Main Effects of Calf Blood Deproteinized Medicine (Actovegin®) in Ischemic Stroke.Int J Mol Sci. 2020 Apr 30;21(9):3181. doi: 10.3390/ijms21093181. Int J Mol Sci. 2020. PMID: 32365943 Free PMC article.
-
Radioprotective effects of a protein-free hemodialysate in human epidermis.Skin Pharmacol. 1996;9(3):197-202. doi: 10.1159/000211416. Skin Pharmacol. 1996. PMID: 8737917
-
Neuroprotective and anti-oxidative effects of the hemodialysate actovegin on primary rat neurons in vitro.Neuromolecular Med. 2011 Dec;13(4):266-74. doi: 10.1007/s12017-011-8157-7. Epub 2011 Oct 9. Neuromolecular Med. 2011. PMID: 21983748 Free PMC article.
Cited by
-
Actovegin reduces the ROS level in blood samples of heart failure patients and diminishes necrosis of SK-N-SH human neuroblastoma cells.Dokl Biol Sci. 2013 Jan;448:57-60. doi: 10.1134/S0012496613010055. Epub 2013 Mar 12. Dokl Biol Sci. 2013. PMID: 23479022 No abstract available.
-
Actovegin in the management of patients after ischemic stroke: A systematic review.PLoS One. 2022 Jun 30;17(6):e0270497. doi: 10.1371/journal.pone.0270497. eCollection 2022. PLoS One. 2022. PMID: 35771887 Free PMC article.
-
A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design.Dement Geriatr Cogn Dis Extra. 2013 Dec 14;3(1):459-67. doi: 10.1159/000357122. eCollection 2013 Jan. Dement Geriatr Cogn Dis Extra. 2013. PMID: 24516413 Free PMC article.
-
Growth factors for treating diabetic foot ulcers.Cochrane Database Syst Rev. 2015 Oct 28;2015(10):CD008548. doi: 10.1002/14651858.CD008548.pub2. Cochrane Database Syst Rev. 2015. PMID: 26509249 Free PMC article.
-
Evaluation of the effect of nano-hydroxyapatite/silica gel bone graft and/or hemodialysate paste on the regeneration and nano-mechanical properties of calvarial bone in gammairradiated albino rats.Oral Maxillofac Surg. 2025 Jun 4;29(1):116. doi: 10.1007/s10006-025-01413-8. Oral Maxillofac Surg. 2025. PMID: 40461642 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources